CLDX
Celldex Therapeutics Inc
31.50$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.0% | +2.1% | +2.8% | -1,555.5% | – | +5.9% | +0.7% | -5.6% | +372.0% | -94.2% | +583.9% | – | |
| – | +1.3% | -0.1% | +6.1% | +25.9% | +1.7% | -4.7% | -1.3% | -4.2% | +1.2% | -4.3% | -1.3% | – | |
| – | -61.7% | -351.0% | – | -784.6% | – | -215.2% | – | +132.5% | -12.9% | -49.1% | +95.1% | – | |
| – | +324.2% | -48.3% | -20.3% | +125.5% | +22.3% | -64.9% | +174.7% | -39.6% | +125.7% | +65.1% | +94.0% | – | |
| – | -1,569.7% | +84.2% | -85.2% | – | -49.6% | +78.6% | +16.1% | +22.1% | -8.9% | +30.1% | -454.3% | – | |
| – | +84,481.3% | +100.6% | -99.1% | -66.6% | -68.8% | -47.7% | -68.8% | +1,128.6% | +74.3% | -75.8% | +99,183.5% | – | |
| – | – | +486.7% | -190.1% | – | – | – | – | +119.9% | -155.2% | – | +71.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.